Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia

Conclusion: Vismodegib has shown meaningful efficacy with DCR from 95% to 100% in patients with laBCC, multiple BCC, and G-G Syn in Slovenia. TEAEs were successfully alleviated with multidisciplinary approach and early supportive care.Dermatology
Source: Dermatology - Category: Dermatology Source Type: research